Paula Deen is facing the music, on the eve of her birthday nonetheless (tomorrow). She and her publicist must have had a phone-a-thon today as she made herself available to the media, inevitably to answer to accusations of hypocrisy, profiteering, and just being a downright bad role model for people with diabetes everywhere. I got a scant 15 minutes on the phone with her, and all I can say is, she sure sounded like a…Read more »
In case you haven’t heard, famous butter-and-cream Southern supreme chef Paula Deen has announced that she is a type 2 diabetic… and that she has partnered with Novo Nordisk in a campaign promoting their drug, Victoza. The way the Internet is all abuzz with this news, you’d think President Obama had been diagnosed with diabetes. But apparently the fact that Paula Deen, renowned for her carb-laden cookbooks and television shows, now has type 2 diabetes…Read more »
As we all know, there’s A LOT to remember when it comes to diabetes. So Timesulin, a virtual company founded in 2009 in Germany, Sweden and the UK, hopes to help patients remember whether or not they’ve taken their insulin injection.
Unlike insulin pumps, most insulin pens don’t come with a memory that you can scroll through to check whether or not you already bolused for your dinner. What to do if you’re unsure? Not…
It’s not too often we have a new insulin making its way on the scene, so we were excited to hear that Novo Nordisk filed two applications with the FDA for a new “ultra long acting” insulin called Degludec, and another for something called DegludecPlus, a combination of degludec and insulin aspart (Novolog), which would be available in an insulin pen in a fixed 70% degludec/30% Novolog ratio. The company is hoping for FDA approval…Read more »
Health professionals reportedly are receiving letters this week alerting them to an FDA warning just issued about risks of thyroid cancer and pancreatitis associated with the popular type 2 diabetes drug liraglutide (Victoza). Yikes!
According to MSM reports, the evidence was found in mice, and it’s unclear if the serious risks translate to humans — but there was enough concern to issue the follow warning:
“Clinical trials have shown more cases of pancreatitis with liraglutide…